NT 10-K 1 t65026_nt10k.htm FORM 12B-25 t65026_nt10k.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 12b-25

Commission File Number 000-52622


NOTIFICATION OF LATE FILING


(Check One):
x Form 10-K
o Form 11-K
o Form 20-F
o Form 10-Q
 
o Form N-SAR
     

   
For Period Ended: 12/31/2008
     
 
o
Transition Report on Form 10-K
     
 
o
Transition Report on Form 20-F
     
 
o
Transition Report on Form 11-K
     
 
o
Transition Report on Form 10-Q
     
 
o
Transition Report on Form N-SAR
     
   
For the Transition Period Ended:

Read attached instruction sheet before preparing form.  Please print or type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:
 
PART I
REGISTRANT INFORMATION
 
Green Planet Bioengineering Co., Limited
Full Name of Registrant

Mondo Acquisition II, Inc
Former Name if Applicable

18851 NE 29th Avenue, Suite 800
Address of Principal Executive Office (Street and Number)

Aventura, Florida 33180
City, State and Zip Code
 

 
PART II
RULE 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense  and  the  registrant  seeks  relief  pursuant  to Rule  12b-25(b),  the following should be completed. (Check box if appropriate.)

 
(a)
The reasons described in reasonable detail in Part III of this form could not be eliminated  without  unreasonable  effort or expense;
     
x
(b)
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K or Form N-SAR, or portion thereof will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and
     
 
(c)
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
 
PART III
NARRATIVE

State below in reasonable detail why the Form 10-K, 11-K, 20-F 10-Q, N-SAR or the transition report portion thereof could not be filed within the prescribed time period. (Attach extra sheets if needed.)

The Company’s Annual Report on Form 10-K for the annual period ended December 31, 2008 cannot be filed within the prescribed time period because the Company requires additional time for compilation and review to insure adequate disclosure of certain information required to be included in the Form 10-K.  The Company’s Annual Report on Form 10-K will be filed on or before the 15th calendar day following the prescribed due date.
 
PART IV
OTHER INFORMATION

(1)
Name and telephone number of person to contact in regard to this notification


 
Mr. Min Zhao
877
544 2288
 
(Name)
(Area Code)
(Telephone Number)

(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
x Yes  o No

(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
x Yes  o No

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

The Company has changed from being a shell company to an operating entity and therefore the results of the operations will change significantly. For further details regarding the company’s operations, please see the Form 8-K filed with the SEC on October 29, 2008.


Green Planet Bioengineering Co., Limited

(Name of Registrant as Specified in Charter)
 

 
Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
 
Date
03/31/2008
 
By
/s/ Mr. Min Zhao
 
       
Mr. Min Zhao
 
       
Chief Executive Officer
 

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed with the form.


ATTENTION

Intentional misstatements or omissions of fact constitute Federal Criminal Violations (see 18 U.S.C. 1001).